(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hyatt Regency Bethesda

Oct 01, 2013 8:30 AM - Oct 02, 2013 3:30 PM

One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814-5326

Clinical Trial Disclosure: Towards a More Transparent World

Back to Agenda

Session 4: Panel Discussion - Impact of Increasing Regulatory Transparency on Publications

Session Chair(s)

Laura A. Hagan

Laura A. Hagan

Global Head Clinical Disclosure Office

Novartis Pharmaceuticals Corporation, United States

This session will consist of a panel of journal editors, academic clinical researchers, and industry publication coordinators discussing the impact of increasing regulatory disclosure requirements.

Speaker(s)

Christine Laine, MD, MPH

Panelist

Christine Laine, MD, MPH

American College of Physicians, United States

Senior Vice President; Editor, Annals of Internal Medicine

Joseph Ross, MD, MHS

Panelist

Joseph Ross, MD, MHS

Yale University School of Medicine, United States

Professor of Medicine and Public Health

Michel Krumenacker, MD

Panelist

Michel Krumenacker, MD

Retired - Formerly Sanofi, United States

Retired

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.